5/13
08:20 am
mlys
We Think Mineralys Therapeutics (NASDAQ:MLYS) Can Afford To Drive Business Growth [Yahoo! Finance]
Medium
Report
We Think Mineralys Therapeutics (NASDAQ:MLYS) Can Afford To Drive Business Growth [Yahoo! Finance]
5/9
07:03 am
mlys
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
5/9
07:00 am
mlys
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
5/6
08:13 am
mlys
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference [Yahoo! Finance]
Medium
Report
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference [Yahoo! Finance]
5/6
08:00 am
mlys
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
Medium
Report
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
5/2
08:00 am
mlys
Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024
Low
Report
Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024
4/2
08:10 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $30.00 price target on the stock.
Medium
Report
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $30.00 price target on the stock.
3/28
07:50 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "outperform" rating re-affirmed by analysts at Lifesci Capital.
Low
Report
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "outperform" rating re-affirmed by analysts at Lifesci Capital.
3/22
10:59 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/21
07:17 am
mlys
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/21
07:00 am
mlys
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Medium
Report
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
3/18
07:26 am
mlys
Mineralys Therapeutics: A Story To Keep An Eye On [Seeking Alpha]
Low
Report
Mineralys Therapeutics: A Story To Keep An Eye On [Seeking Alpha]
3/13
04:05 pm
mlys
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024
Low
Report
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024